Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) Short Interest Up 65.5% in November

Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) was the recipient of a significant growth in short interest in the month of November. As of November 15th, there was short interest totalling 38,900 shares, a growth of 65.5% from the October 31st total of 23,500 shares. Based on an average daily volume of 36,700 shares, the short-interest ratio is presently 1.1 days. Approximately 2.3% of the shares of the stock are sold short.

Creative Medical Technology Trading Up 0.6 %

Shares of CELZ opened at $2.67 on Friday. Creative Medical Technology has a twelve month low of $2.41 and a twelve month high of $10.28. The firm has a market capitalization of $4.66 million, a P/E ratio of -0.70 and a beta of 2.01. The firm’s 50-day moving average is $3.32 and its two-hundred day moving average is $3.56.

Institutional Investors Weigh In On Creative Medical Technology

An institutional investor recently bought a new position in Creative Medical Technology stock. Virtu Financial LLC bought a new stake in shares of Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) in the 1st quarter, according to its most recent 13F filing with the SEC. The firm bought 16,374 shares of the company’s stock, valued at approximately $85,000. Virtu Financial LLC owned approximately 1.21% of Creative Medical Technology at the end of the most recent quarter. Institutional investors own 1.42% of the company’s stock.

About Creative Medical Technology

Creative Medical Technology Holdings, Inc, a commercial stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; and StemSpine, a regenerative stem cell procedure to treat degenerative disc disease.